Muddapu VR, Mandali A, Chakravarthy VS, Ramaswamy S. (2019). A Computational Model of Loss of Dopaminergic Cells in Parkinson's Disease Due to Glutamate-Induced Excitotoxicity. Frontiers in neural circuits. 13 [PubMed]

See more from authors: Muddapu VR · Mandali A · Chakravarthy VS · Ramaswamy S

References and models cited by this paper

Abbott LF, Dayan P. (2005). Theoretical neuroscience: computational and mathematical modeling of neural systems.

Adhihetty PJ, Beal MF. (2008). Creatine and its potential therapeutic value for targeting cellular energy impairment in neurodegenerative diseases. Neuromolecular medicine. 10 [PubMed]

Albin RL, Greenamyre JT. (1992). Alternative excitotoxic hypotheses. Neurology. 42 [PubMed]

Alvarez L et al. (2009). Therapeutic efficacy of unilateral subthalamotomy in Parkinson's disease: results in 89 patients followed for up to 36 months. Journal of neurology, neurosurgery, and psychiatry. 80 [PubMed]

Ambrosi G, Cerri S, Blandini F. (2014). A further update on the role of excitotoxicity in the pathogenesis of Parkinson's disease. Journal of neural transmission (Vienna, Austria : 1996). 121 [PubMed]

Ammari R, Bioulac B, Garcia L, Hammond C. (2011). The Subthalamic Nucleus becomes a Generator of Bursts in the Dopamine-Depleted State. Its High Frequency Stimulation Dramatically Weakens Transmission to the Globus Pallidus. Frontiers in systems neuroscience. 5 [PubMed]

Anselmi L et al. (2018). Ingestion of subthreshold doses of environmental toxins induces ascending Parkinsonism in the rat. NPJ Parkinson's disease. 4 [PubMed]

Arbuthnott GW, Atherton JF, Wright AK, McLaughlin KE, Norrie L. (2002). Lesions of the rat globus pallidus, which increase subthalamic nucleus activity, cause dopamine cell death The Basal Ganglia VII.

Armentero MT, Fancellu R, Nappi G, Bramanti P, Blandini F. (2006). Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's disease. Neurobiology of disease. 22 [PubMed]

Austin PJ et al. (2010). Symptomatic and neuroprotective effects following activation of nigral group III metabotropic glutamate receptors in rodent models of Parkinson's disease. British journal of pharmacology. 160 [PubMed]

Battaglia G et al. (2003). Protective role of group-II metabotropic glutamate receptors against nigro-striatal degeneration induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Neuropharmacology. 45 [PubMed]

Beal MF, Hyman BT, Koroshetz W. (1993). Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? Trends in neurosciences. 16 [PubMed]

Benazzouz A et al. (2000). Implication of the subthalamic nucleus in the pathophysiology and pathogenesis of Parkinson's disease. Cell transplantation. 9 [PubMed]

Bergman H et al. (1998). Physiological aspects of information processing in the basal ganglia of normal and parkinsonian primates. Trends in neurosciences. 21 [PubMed]

Bergman H, Wichmann T, Karmon B, DeLong MR. (1994). The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. Journal of neurophysiology. 72 [PubMed]

Betts MJ, O'Neill MJ, Duty S. (2012). Allosteric modulation of the group III mGlu4 receptor provides functional neuroprotection in the 6-hydroxydopamine rat model of Parkinson's disease. British journal of pharmacology. 166 [PubMed]

Beurrier C, Congar P, Bioulac B, Hammond C. (1999). Subthalamic nucleus neurons switch from single-spike activity to burst-firing mode. The Journal of neuroscience : the official journal of the Society for Neuroscience. 19 [PubMed]

Bezard E, Boraud T, Bioulac B, Gross CE. (1999). Involvement of the subthalamic nucleus in glutamatergic compensatory mechanisms. The European journal of neuroscience. 11 [PubMed]

Bezard E et al. (2001). Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease. The Journal of neuroscience : the official journal of the Society for Neuroscience. 21 [PubMed]

Bezard E, Gross CE, Brotchie JM. (2003). Presymptomatic compensation in Parkinson's disease is not dopamine-mediated. Trends in neurosciences. 26 [PubMed]

Blandini F. (2001). The role of the subthalamic nucleus in the pathophysiology of Parkinson's disease. Functional neurology. 16 [PubMed]

Blandini F. (2010). An update on the potential role of excitotoxicity in the pathogenesis of Parkinson's disease. Functional neurology. 25 [PubMed]

Bolam JP, Pissadaki EK. (2012). Living on the edge with too many mouths to feed: why dopamine neurons die. Movement disorders : official journal of the Movement Disorder Society. 27 [PubMed]

Booth HDE, Hirst WD, Wade-Martins R. (2017). The Role of Astrocyte Dysfunction in Parkinson's Disease Pathogenesis. Trends in neurosciences. 40 [PubMed]

Brouillet E, Beal MF. (1993). NMDA antagonists partially protect against MPTP induced neurotoxicity in mice. Neuroreport. 4 [PubMed]

Brown P. (2003). Oscillatory nature of human basal ganglia activity: relationship to the pathophysiology of Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society. 18 [PubMed]

Brown P et al. (2001). Dopamine dependency of oscillations between subthalamic nucleus and pallidum in Parkinson's disease. The Journal of neuroscience : the official journal of the Society for Neuroscience. 21 [PubMed]

Carron R, Chaillet A, Filipchuk A, Pasillas-Lépine W, Hammond C. (2013). Closing the loop of deep brain stimulation. Frontiers in systems neuroscience. 7 [PubMed]

Carvalho GA, Nikkhah G. (2001). Subthalamic nucleus lesions are neuroprotective against terminal 6-OHDA-induced striatal lesions and restore postural balancing reactions. Experimental neurology. 171 [PubMed]

Chakravarthy SV, Muddapu VR. (2017). Programmed cell death in substantia nigra due to subthalamic nucleus-mediated excitotoxicity: a computational model of Parkinsonian neurodegeneration BMC Neurosci.. 18

Chakravarthy SV, Ramaswamy S, Mandali A, Muddapu VR. (2018). A computational model of loss of dopaminergic cells in Parkinson's disease due to glutamate-induced excitotoxicity bioRXiv.

Chan H et al. (2010). Neuroprotection and Functional Recovery Associated with Decreased Microglial Activation Following Selective Activation of mGluR2/3 Receptors in a Rodent Model of Parkinson's Disease. Parkinson's disease. 2010 [PubMed]

Chander BS, Chakravarthy VS. (2012). A computational model of neuro-glio-vascular loop interactions. PloS one. 7 [PubMed]

Chen L, Liu Z, Tian Z, Wang Y, Li S. (2000). Prevention of neurotoxin damage of 6-OHDA to dopaminergic nigral neuron by subthalamic nucleus lesions. Stereotactic and functional neurosurgery. 75 [PubMed]

Chhabria K, Chakravarthy VS. (2016). Low-Dimensional Models of "Neuro-Glio-Vascular Unit" for Describing Neural Dynamics under Normal and Energy-Starved Conditions. Frontiers in neurology. 7 [PubMed]

Chiken S, Nambu A. (2016). Mechanism of Deep Brain Stimulation: Inhibition, Excitation, or Disruption? The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry. 22 [PubMed]

Chiti F, Dobson CM. (2017). Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade. Annual review of biochemistry. 86 [PubMed]

Cogan SF. (2008). Neural stimulation and recording electrodes. Annual review of biomedical engineering. 10 [PubMed]

Courtney NA, Mamaligas AA, Ford CP. (2012). Species differences in somatodendritic dopamine transmission determine D2-autoreceptor-mediated inhibition of ventral tegmental area neuron firing. The Journal of neuroscience : the official journal of the Society for Neuroscience. 32 [PubMed]

Cragg SJ, Baufreton J, Xue Y, Bolam JP, Bevan MD. (2004). Synaptic release of dopamine in the subthalamic nucleus. The European journal of neuroscience. 20 [PubMed]

Cullen M, Wong-Lin K. (2015). Integrated dopaminergic neuronal model with reduced intracellular processes and inhibitory autoreceptors. IET systems biology. 9 [PubMed]

Dovzhenok A, Rubchinsky LL. (2012). On the origin of tremor in Parkinson's disease. PloS one. 7 [PubMed]

Ebert M, Hauptmann C, Tass PA. (2014). Coordinated reset stimulation in a large-scale model of the STN-GPe circuit. Frontiers in computational neuroscience. 8 [PubMed]

Et AL, Ortiz G. G., Pacheco-Moisés, F. P., Mireles-Ramírez, M. A., Flores-Alvarado, LJ, González-Usigli H, Sánchez-López AL. (2016). Oxidative stress and Parkinson's disease: effects on environmental toxicology Free Radicals and Diseases,.

Fan KY, Baufreton J, Surmeier DJ, Chan CS, Bevan MD. (2012). Proliferation of external globus pallidus-subthalamic nucleus synapses following degeneration of midbrain dopamine neurons. The Journal of neuroscience : the official journal of the Society for Neuroscience. 32 [PubMed]

Fenoy AJ, Goetz L, Chabardès S, Xia Y. (2014). Deep brain stimulation: are astrocytes a key driver behind the scene? CNS neuroscience & therapeutics. 20 [PubMed]

Ferrigno A et al. (2015). Selective blockade of mGlu5 metabotropic glutamate receptors is protective against hepatic mitochondrial dysfunction in 6-OHDA lesioned Parkinsonian rats. Clinical and experimental pharmacology & physiology. 42 [PubMed]

Ford CP. (2014). The role of D2-autoreceptors in regulating dopamine neuron activity and transmission. Neuroscience. 282 [PubMed]

Foutz TJ, McIntyre CC. (2010). Evaluation of novel stimulus waveforms for deep brain stimulation. Journal of neural engineering. 7 [PubMed]

Fuzzati-Armentero MT et al. (2015). Dual target strategy: combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates L-DOPA-induced rotational behavior in a rodent model of Parkinson's disease. Journal of neurochemistry. 134 [PubMed]

Gandrakota R, Chakravarthy VS, Pradhan RK. (2010). A model of indispensability of a large glial layer in cerebrovascular circulation. Neural computation. 22 [PubMed]

Gao J et al. (2017). Abnormalities of Mitochondrial Dynamics in Neurodegenerative Diseases. Antioxidants (Basel, Switzerland). 6 [PubMed]

Garcia L, D'Alessandro G, Bioulac B, Hammond C. (2005). High-frequency stimulation in Parkinson's disease: more or less? Trends in neurosciences. 28 [PubMed]

German DC, Manaye KF, Sonsalla PK, Brooks BA. (1992). Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism: sparing of calbindin-D28k-containing cells. Annals of the New York Academy of Sciences. 648 [PubMed]

Giguère N, Burke Nanni S, Trudeau LE. (2018). On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson's Disease. Frontiers in neurology. 9 [PubMed]

Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH. (2010). Mechanisms underlying inflammation in neurodegeneration. Cell. 140 [PubMed]

Golomb D. (2007). Neuronal synchrony measures Scholarpedia. 2

Grace AA, Bunney BS. (1983). Intracellular and extracellular electrophysiology of nigral dopaminergic neurons--1. Identification and characterization. Neuroscience. 10 [PubMed]

Grace AA, Bunney BS. (1984). The control of firing pattern in nigral dopamine neurons: burst firing. The Journal of neuroscience : the official journal of the Society for Neuroscience. 4 [PubMed]

Grace AA, Bunney BS. (1984). The control of firing pattern in nigral dopamine neurons: single spike firing. The Journal of neuroscience : the official journal of the Society for Neuroscience. 4 [PubMed]

Grandas F. (2000). The putative neuroprotective role of dopamine agonists in Parkinson's disease. Neurotoxicity research. 2 [PubMed]

Greene JG, Greenamyre JT. (1996). Bioenergetics and glutamate excitotoxicity. Progress in neurobiology. 48 [PubMed]

Guridi J, Marigil M, Becerra V, Parras O. (2016). [Neuroprotective subthalamotomy in Parkinson's disease. The role of magnetic resonance-guided focused ultrasound in early surgery]. Neurocirugia (Asturias, Spain). 27 [PubMed]

Guridi J, Obeso JA. (2015). Letter to the editor: Parkinson's disease and early subthalamotomy. Journal of neurosurgery. 122 [PubMed]

Götz T et al. (1997). Functional properties of AMPA and NMDA receptors expressed in identified types of basal ganglia neurons. The Journal of neuroscience : the official journal of the Society for Neuroscience. 17 [PubMed]

Hamani C et al. (2017). Subthalamic Nucleus Deep Brain Stimulation: Basic Concepts and Novel Perspectives. eNeuro. 4 [PubMed]

Hamani C, Saint-Cyr JA, Fraser J, Kaplitt M, Lozano AM. (2004). The subthalamic nucleus in the context of movement disorders. Brain : a journal of neurology. 127 [PubMed]

Hammond C, Ammari R, Bioulac B, Garcia L. (2008). Latest view on the mechanism of action of deep brain stimulation. Movement disorders : official journal of the Movement Disorder Society. 23 [PubMed]

Hansel D, Mato G, Meunier C. (1995). Synchrony in excitatory neural networks. Neural computation. 7 [PubMed]

Hassani OK, François C, Yelnik J, Féger J. (1997). Evidence for a dopaminergic innervation of the subthalamic nucleus in the rat. Brain research. 749 [PubMed]

Hasselmo ME. (1994). Runaway synaptic modification in models of cortex: implications for Alzheimers disease Neural Networks. 7

Hasselmo ME. (1997). A computational model of the progression of Alzheimer's disease. M.D. computing : computers in medical practice. 14 [PubMed]

Hauptmann C, Tass PA. (2007). Therapeutic rewiring by means of desynchronizing brain stimulation. Bio Systems. 89 [PubMed]

Hebb MO, Robertson HA. (2000). Identification of a subpopulation of substantia nigra pars compacta gamma-aminobutyric acid neurons that is regulated by basal ganglia activity. The Journal of comparative neurology. 416 [PubMed]

Hegeman DJ, Hong ES, Hernández VM, Chan CS. (2016). The external globus pallidus: progress and perspectives. The European journal of neuroscience. 43 [PubMed]

Henchcliffe C, Beal MF. (2008). Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nature clinical practice. Neurology. 4 [PubMed]

Hofmann L, Ebert M, Tass PA, Hauptmann C. (2011). Modified pulse shapes for effective neural stimulation. Frontiers in neuroengineering. 4 [PubMed]

Hsieh MH et al. (2012). Blockade of metabotropic glutamate receptors inhibits cognition and neurodegeneration in an MPTP-induced Parkinson's disease rat model. Pharmacology, biochemistry, and behavior. 102 [PubMed]

Humphries MD, Stewart RD, Gurney KN. (2006). A physiologically plausible model of action selection and oscillatory activity in the basal ganglia. The Journal of neuroscience : the official journal of the Society for Neuroscience. 26 [PubMed]

Hwang O. (2013). Role of oxidative stress in Parkinson's disease. Experimental neurobiology. 22 [PubMed]

Iglesias J, Villa AE. (2008). Emergence of preferred firing sequences in large spiking neural networks during simulated neuronal development. International journal of neural systems. 18 [PubMed]

Izhikevich E. (2006). Bursting Scholarpedia http:--www.scholarpedia.org-article-Burst.

Izhikevich EM. (2003). Simple model of spiking neurons. IEEE transactions on neural networks. 14 [PubMed]

Jahr CE, Stevens CF. (1990). Voltage dependence of NMDA-activated macroscopic conductances predicted by single-channel kinetics. The Journal of neuroscience : the official journal of the Society for Neuroscience. 10 [PubMed]

Jang JY et al. (2011). Regulation of dopaminergic neuron firing by heterogeneous dopamine autoreceptors in the substantia nigra pars compacta. Journal of neurochemistry. 116 [PubMed]

Johnson SW. (2008). Rebound bursts following inhibition: how dopamine modifies firing pattern in subthalamic neurons. The Journal of physiology. 586 [PubMed]

Johri A, Beal MF. (2012). Mitochondrial dysfunction in neurodegenerative diseases. The Journal of pharmacology and experimental therapeutics. 342 [PubMed]

Jourdain VA, Schechtmann G, Di Paolo T. (2014). Subthalamotomy in the treatment of Parkinson's disease: clinical aspects and mechanisms of action. Journal of neurosurgery. 120 [PubMed]

Kang G, Lowery MM. (2013). Interaction of oscillations, and their suppression via deep brain stimulation, in a model of the cortico-basal ganglia network. IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society. 21 [PubMed]

Kang G, Lowery MM. (2014). Effects of antidromic and orthodromic activation of STN afferent axons during DBS in Parkinson's disease: a simulation study. Frontiers in computational neuroscience. 8 [PubMed]

Kita H, Chang HT, Kitai ST. (1983). The morphology of intracellularly labeled rat subthalamic neurons: a light microscopic analysis. The Journal of comparative neurology. 215 [PubMed]

Kita H, Kita T. (2011). Role of Striatum in the Pause and Burst Generation in the Globus Pallidus of 6-OHDA-Treated Rats. Frontiers in systems neuroscience. 5 [PubMed]

Kita H, Kitai ST. (1987). Efferent projections of the subthalamic nucleus in the rat: light and electron microscopic analysis with the PHA-L method. The Journal of comparative neurology. 260 [PubMed]

Kita H, Kitai ST. (1994). The morphology of globus pallidus projection neurons in the rat: an intracellular staining study. Brain research. 636 [PubMed]

Lawson LJ, Perry VH, Dri P, Gordon S. (1990). Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience. 39 [PubMed]

Ledonne A, Mango D, Bernardi G, Berretta N, Mercuri NB. (2012). A continuous high frequency stimulation of the subthalamic nucleus determines a suppression of excitatory synaptic transmission in nigral dopaminergic neurons recorded in vitro. Experimental neurology. 233 [PubMed]

Lee HH et al. (2003). Differential effects of natural polyphenols on neuronal survival in primary cultured central neurons against glutamate- and glucose deprivation-induced neuronal death. Brain research. 986 [PubMed]

Lee KH, Bieber AJ, Duffy PS. (2016). Deep Brain Stimulation: Indications and Applications.

Lee KH, Chang SY, Roberts DW, Kim U. (2004). Neurotransmitter release from high-frequency stimulation of the subthalamic nucleus. Journal of neurosurgery. 101 [PubMed]

Liang CL, Nelson O, Yazdani U, Pasbakhsh P, German DC. (2004). Inverse relationship between the contents of neuromelanin pigment and the vesicular monoamine transporter-2: human midbrain dopamine neurons. The Journal of comparative neurology. 473 [PubMed]

Lindahl M, Kamali Sarvestani I, Ekeberg O, Kotaleski JH. (2013). Signal enhancement in the output stage of the basal ganglia by synaptic short-term plasticity in the direct, indirect, and hyperdirect pathways. Frontiers in computational neuroscience. 7 [PubMed]

Lintas A, Silkis IG, Albéri L, Villa AE. (2012). Dopamine deficiency increases synchronized activity in the rat subthalamic nucleus. Brain research. 1434 [PubMed]

Litvak V et al. (2011). Resting oscillatory cortico-subthalamic connectivity in patients with Parkinson's disease. Brain : a journal of neurology. 134 [PubMed]

Lukasiewicz PD, Werblin FS. (1990). The spatial distribution of excitatory and inhibitory inputs to ganglion cell dendrites in the tiger salamander retina. The Journal of neuroscience : the official journal of the Society for Neuroscience. 10 [PubMed]

Maesawa S et al. (2004). Long-term stimulation of the subthalamic nucleus in hemiparkinsonian rats: neuroprotection of dopaminergic neurons. Journal of neurosurgery. 100 [PubMed]

Magill PJ, Bolam JP, Bevan MD. (2001). Dopamine regulates the impact of the cerebral cortex on the subthalamic nucleus-globus pallidus network. Neuroscience. 106 [PubMed]

Mamad O, Delaville C, Benjelloun W, Benazzouz A. (2015). Dopaminergic control of the globus pallidus through activation of D2 receptors and its impact on the electrical activity of subthalamic nucleus and substantia nigra reticulata neurons. PloS one. 10 [PubMed]

Mandali A, Chakravarthy VS. (2016). Probing the Role of Medication, DBS Electrode Position, and Antidromic Activation on Impulsivity Using a Computational Model of Basal Ganglia. Frontiers in human neuroscience. 10 [PubMed]

Mandali A, Rengaswamy M, Chakravarthy VS, Moustafa AA. (2015). A spiking Basal Ganglia model of synchrony, exploration and decision making. Frontiers in neuroscience. 9 [PubMed]

Masilamoni GJ et al. (2011). Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys. Brain : a journal of neurology. 134 [PubMed]

McDougal RA et al. (2017). Twenty years of ModelDB and beyond: building essential modeling tools for the future of neuroscience. Journal of computational neuroscience. 42 [PubMed]

McGeer PL, McGeer EG. (2008). Glial reactions in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society. 23 [PubMed]

McIntyre CC, Mori S, Sherman DL, Thakor NV, Vitek JL. (2004). Electric field and stimulating influence generated by deep brain stimulation of the subthalamic nucleus. Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology. 115 [PubMed]

Meissner W et al. (2005). Subthalamic high frequency stimulation resets subthalamic firing and reduces abnormal oscillations. Brain : a journal of neurology. 128 [PubMed]

Mena MA, García de Yébenes J. (2008). Glial cells as players in parkinsonism: the "good," the "bad," and the "mysterious" glia. The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry. 14 [PubMed]

Mergenthaler P, Lindauer U, Dienel GA, Meisel A. (2013). Sugar for the brain: the role of glucose in physiological and pathological brain function. Trends in neurosciences. 36 [PubMed]

Merino M, Vizuete ML, Cano J, Machado A. (1999). The non-NMDA glutamate receptor antagonists 6-cyano-7-nitroquinoxaline-2,3-dione and 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(f)quinoxaline, but not NMDA antagonists, block the intrastriatal neurotoxic effect of MPP+. Journal of neurochemistry. 73 [PubMed]

Michmizos KP, Nikita KS. (2011). Addition of deep brain stimulation signal to a local field potential driven Izhikevich model masks the pathological firing pattern of an STN neuron. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference. 2011 [PubMed]

Modolo J, Mosekilde E, Beuter A. (2007). New insights offered by a computational model of deep brain stimulation. Journal of physiology, Paris. 101 [PubMed]

Montgomery EB, Gale JT. (2008). Mechanisms of action of deep brain stimulation(DBS) . Neuroscience and biobehavioral reviews. 32 [PubMed]

Moran A, Stein E, Tischler H, Bar-Gad I. (2012). Decoupling neuronal oscillations during subthalamic nucleus stimulation in the parkinsonian primate. Neurobiology of disease. 45 [PubMed]

Moran A, Stein E, Tischler H, Belelovsky K, Bar-Gad I. (2011). Dynamic stereotypic responses of Basal Ganglia neurons to subthalamic nucleus high-frequency stimulation in the parkinsonian primate. Frontiers in systems neuroscience. 5 [PubMed]

Moro E et al. (2002). The impact on Parkinson's disease of electrical parameter settings in STN stimulation. Neurology. 59 [PubMed]

Mosharov EV et al. (2009). Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons. Neuron. 62 [PubMed]

Moustafa AA, Chakravarthy VS. (2018). Computational Neuroscience Models of the Basal Ganglia Cognitive Science and Technology.. 15

Murray TK et al. (2002). Evaluation of the mGluR2/3 agonist LY379268 in rodent models of Parkinson's disease. Pharmacology, biochemistry, and behavior. 73 [PubMed]

Murray TK et al. (2003). LY503430, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's disease. The Journal of pharmacology and experimental therapeutics. 306 [PubMed]

Musacchio T et al. (2017). Subthalamic nucleus deep brain stimulation is neuroprotective in the A53T a-synuclein Parkinson's disease rat model. Annals of neurology. 81 [PubMed]

O'Neill MJ et al. (2004). Neurotrophic actions of the novel AMPA receptor potentiator, LY404187, in rodent models of Parkinson's disease. European journal of pharmacology. 486 [PubMed]

Obeso I et al. (2017). Unilateral subthalamotomy in Parkinson's disease: Cognitive, psychiatric and neuroimaging changes. Cortex; a journal devoted to the study of the nervous system and behavior. 94 [PubMed]

Olanow CW, Jenner P, Brooks D. (1998). Dopamine agonists and neuroprotection in Parkinson's disease. Annals of neurology. 44 [PubMed]

Oorschot DE. (1996). Total number of neurons in the neostriatal, pallidal, subthalamic, and substantia nigral nuclei of the rat basal ganglia: a stereological study using the cavalieri and optical disector methods. The Journal of comparative neurology. 366 [PubMed]

Pacelli C et al. (2015). Elevated Mitochondrial Bioenergetics and Axonal Arborization Size Are Key Contributors to the Vulnerability of Dopamine Neurons. Current biology : CB. 25 [PubMed]

Park C, Worth RM, Rubchinsky LL. (2010). Fine temporal structure of beta oscillations synchronization in subthalamic nucleus in Parkinson's disease. Journal of neurophysiology. 103 [PubMed]

Park C, Worth RM, Rubchinsky LL. (2011). Neural dynamics in parkinsonian brain: the boundary between synchronized and nonsynchronized dynamics. Physical review. E, Statistical, nonlinear, and soft matter physics. 83 [PubMed]

Park SE, Song K-i, Suh J-kF, Youn I. (2015). Characteristics of the neuronal firing patterns in the subthalamic nucleus with graded dopaminergic cell loss in the nigrostriatal pathway Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference (Milan).

Paul G et al. (2004). Ablation of the subthalamic nucleus protects dopaminergic phenotype but not cell survival in a rat model of Parkinson's disease. Experimental neurology. 185 [PubMed]

Pavese N, Piccini P. (2006). State-of-the-art Therapeutic Strategies in Parkinson's Disease Eur. Neurol. Rev.. 6

Pavlides A, Hogan SJ, Bogacz R. (2015). Computational Models Describing Possible Mechanisms for Generation of Excessive Beta Oscillations in Parkinson's Disease. PLoS computational biology. 11 [PubMed]

Peter D et al. (1995). Differential expression of two vesicular monoamine transporters. The Journal of neuroscience : the official journal of the Society for Neuroscience. 15 [PubMed]

Philips RT, Chhabria K, Chakravarthy VS. (2016). Vascular Dynamics Aid a Coupled Neurovascular Network Learn Sparse Independent Features: A Computational Model. Frontiers in neural circuits. 10 [PubMed]

Piallat B, Benazzouz A, Benabid AL. (1996). Subthalamic nucleus lesion in rats prevents dopaminergic nigral neuron degeneration after striatal 6-OHDA injection: behavioural and immunohistochemical studies. The European journal of neuroscience. 8 [PubMed]

Pinsky PF, Rinzel J. (1995). Synchrony measures for biological neural networks. Biological cybernetics. 73 [PubMed]

Pissadaki EK, Bolam JP. (2013). The energy cost of action potential propagation in dopamine neurons: clues to susceptibility in Parkinson's disease. Frontiers in computational neuroscience. 7 [PubMed]

Reeve AK et al. (2018). Mitochondrial dysfunction within the synapses of substantia nigra neurons in Parkinson's disease. NPJ Parkinson's disease. 4 [PubMed]

Rite I, Machado A, Cano J, Venero JL. (2007). Blood-brain barrier disruption induces in vivo degeneration of nigral dopaminergic neurons. Journal of neurochemistry. 101 [PubMed]

Rocha SM, Cristovão AC, Campos FL, Fonseca CP, Baltazar G. (2012). Astrocyte-derived GDNF is a potent inhibitor of microglial activation. Neurobiology of disease. 47 [PubMed]

Rodriguez MC, Obeso JA, Olanow CW. (1998). Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: a target for neuroprotection. Annals of neurology. 44 [PubMed]

Rosenbaum R et al. (2014). Axonal and synaptic failure suppress the transfer of firing rate oscillations, synchrony and information during high frequency deep brain stimulation. Neurobiology of disease. 62 [PubMed]

Rubin JE, Terman D. (2004). High frequency stimulation of the subthalamic nucleus eliminates pathological thalamic rhythmicity in a computational model. Journal of computational neuroscience. 16 [PubMed]

Schapira AH. (2003). Neuroprotection in PD--a role for dopamine agonists? Neurology. 61 [PubMed]

Schapira AH, Olanow CW. (2003). Rationale for the use of dopamine agonists as neuroprotective agents in Parkinson's disease. Annals of neurology. 53 Suppl 3 [PubMed]

Seidl SE, Potashkin JA. (2011). The promise of neuroprotective agents in Parkinson's disease. Frontiers in neurology. 2 [PubMed]

Shen KZ, Johnson SW. (2000). Presynaptic dopamine D2 and muscarine M3 receptors inhibit excitatory and inhibitory transmission to rat subthalamic neurones in vitro. The Journal of physiology. 525 Pt 2 [PubMed]

Shen KZ, Johnson SW. (2008). Complex EPSCs evoked in substantia nigra reticulata neurons are disrupted by repetitive stimulation of the subthalamic nucleus. Synapse (New York, N.Y.). 62 [PubMed]

Shouno O, Tachibana Y, Nambu A, Doya K. (2017). Computational Model of Recurrent Subthalamo-Pallidal Circuit for Generation of Parkinsonian Oscillations. Frontiers in neuroanatomy. 11 [PubMed]

Smith ID, Grace AA. (1992). Role of the subthalamic nucleus in the regulation of nigral dopamine neuron activity. Synapse (New York, N.Y.). 12 [PubMed]

Smith Y, Kieval JZ. (2000). Anatomy of the dopamine system in the basal ganglia. Trends in neurosciences. 23 [PubMed]

Spieles-Engemann AL et al. (2010). Stimulation of the rat subthalamic nucleus is neuroprotective following significant nigral dopamine neuron loss. Neurobiology of disease. 39 [PubMed]

Stykel MG et al. (2018). Nitration of microtubules blocks axonal mitochondrial transport in a human pluripotent stem cell model of Parkinson's disease. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 32 [PubMed]

Sulzer D. (2007). Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease. Trends in neurosciences. 30 [PubMed]

Sulzer D, Surmeier DJ. (2013). Neuronal vulnerability, pathogenesis, and Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society. 28 [PubMed]

Surmeier DJ, Guzman JN, Sanchez-Padilla J, Goldberg JA. (2010). What causes the death of dopaminergic neurons in Parkinson's disease? Progress in brain research. 183 [PubMed]

Surmeier DJ, Obeso JA, Halliday GM. (2017). Selective neuronal vulnerability in Parkinson disease. Nature reviews. Neuroscience. 18 [PubMed]

Temel Y et al. (2006). Protection of nigral cell death by bilateral subthalamic nucleus stimulation. Brain research. 1120 [PubMed]

Tepper JM, Lee CR. (2007). GABAergic control of substantia nigra dopaminergic neurons. Progress in brain research. 160 [PubMed]

Terman D, Rubin JE, Yew AC, Wilson CJ. (2002). Activity patterns in a model for the subthalamopallidal network of the basal ganglia. The Journal of neuroscience : the official journal of the Society for Neuroscience. 22 [PubMed]

Tripathy SJ, Savitskaya J, Burton SD, Urban NN, Gerkin RC. (2014). NeuroElectro: a window to the world's neuron electrophysiology data. Frontiers in neuroinformatics. 8 [PubMed]

Tsai PI et al. (2018). PINK1 Phosphorylates MIC60/Mitofilin to Control Structural Plasticity of Mitochondrial Crista Junctions. Molecular cell. 69 [PubMed]

Turski L, Bressler K, Rettig KJ, Löschmann PA, Wachtel H. (1991). Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists. Nature. 349 [PubMed]

Vaarmann A, Kovac S, Holmström KM, Gandhi S, Abramov AY. (2013). Dopamine protects neurons against glutamate-induced excitotoxicity. Cell death & disease. 4 [PubMed]

Van_ooyen A, Van_elburg RA. (2004). A new measure for bursting Neurocomputing Neurocomputing. 58-60

Vandecasteele M, Glowinski J, Venance L. (2005). Electrical synapses between dopaminergic neurons of the substantia nigra pars compacta. The Journal of neuroscience : the official journal of the Society for Neuroscience. 25 [PubMed]

Vernon AC et al. (2005). Neuroprotective effects of metabotropic glutamate receptor ligands in a 6-hydroxydopamine rodent model of Parkinson's disease. The European journal of neuroscience. 22 [PubMed]

Vila M et al. (2000). Evolution of changes in neuronal activity in the subthalamic nucleus of rats with unilateral lesion of the substantia nigra assessed by metabolic and electrophysiological measurements. The European journal of neuroscience. 12 [PubMed]

Waak J et al. (2009). Regulation of astrocyte inflammatory responses by the Parkinson's disease-associated gene DJ-1. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 23 [PubMed]

Wallace BA et al. (2007). Survival of midbrain dopaminergic cells after lesion or deep brain stimulation of the subthalamic nucleus in MPTP-treated monkeys. Brain : a journal of neurology. 130 [PubMed]

Walters JR, Allers KA, Kreiss DS. (2003). euronal firing patterns in the subthalamic nucleus The Basal Ganglia.

Walters JR, Kreiss DS, Mastropietro CW, Rawji SS. (1997). The response of subthalamic nucleus neurons to dopamine receptor stimulation in a rodent model of Parkinson's disease. J Neurosci. 17

Wang XJ, Rinzel J. (1993). Spindle rhythmicity in the reticularis thalami nucleus: synchronization among mutually inhibitory neurons. Neuroscience. 53 [PubMed]

Weinberger M et al. (2006). Beta oscillatory activity in the subthalamic nucleus and its relation to dopaminergic response in Parkinson's disease. Journal of neurophysiology. 96 [PubMed]

Wellstead P. (2010). Systems biology and the spirit of tustin IEEE Control Syst. 30

Wellstead P, Cloutier M. (2011). An energy systems approach to Parkinson's disease. Wiley interdisciplinary reviews. Systems biology and medicine. 3 [PubMed]

Whitton PS. (2007). Inflammation as a causative factor in the aetiology of Parkinson's disease. British journal of pharmacology. 150 [PubMed]

Wright AK, Arbuthnott GW. (2007). The influence of the subthalamic nucleus upon the damage to the dopamine system following lesions of globus pallidus in rats. The European journal of neuroscience. 26 [PubMed]

Yang C et al. (2016). D2 dopamine receptors modulate neuronal resonance in subthalamic nucleus and cortical high-voltage spindles through HCN channels. Neuropharmacology. 105 [PubMed]

Zecca L et al. (2008). Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease. Acta neuropathologica. 116 [PubMed]

Zhang J, Tan LC. (2016). Revisiting the Medical Management of Parkinson's Disease: Levodopa versus Dopamine Agonist. Current neuropharmacology. 14 [PubMed]

Zhang W et al. (2011). Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson's disease. Neurotoxicity research. 19 [PubMed]

Zheng F et al. (2011). Axonal failure during high frequency stimulation of rat subthalamic nucleus. The Journal of physiology. 589 [PubMed]

Zuddas A et al. (1992). MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in primates. Journal of neurochemistry. 59 [PubMed]

Zuddas A et al. (1992). Pharmacologic modulation of MPTP toxicity: MK 801 in prevention of dopaminergic cell death in monkeys and mice. Annals of the New York Academy of Sciences. 648 [PubMed]

References and models that cite this paper
This website requires cookies and limited processing of your personal data in order to function. By continuing to browse or otherwise use this site, you are agreeing to this use. See our Privacy policy and how to cite and terms of use.